Increasing Number of Chronic Wounds, Ulcers and Diabetic Ulcers
According to NCBI, more than 9.3 percent of United States population which is estimated around 29.1 million people, is affected by diabetes. In adults who are aged over 65 years, the percent of population suffering with diabetes is more than 25 percent. The incidence of chronic wounds especially foot ulcers increases among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, It is also estimated that patient with diabetes are 10 times more likely to undergo amputation at some point in their life. The number of diabetes patients are expected to increase with increasing geriatric population which in turn will drive the market for wound care management in the forecast period.
In addition, increase in surgical procedures worldwide along with increasing ageing population is also fuelling the growth of advance wound care management market.
High Treatment Costs
Wound care management is associated with high costs due to which it has a low adoption rate. According to a breakdown of wound costs provided by Smith & Nephew, 15-20% are material costs, 30-35% are nurse costs and more than 50% are hospitalization costs. Since, the hospitalization in necessary until the wound is dried, the high hospitalization costs is hindering the advance wound care management market globally.
Additionally, lack of reimbursement policies all over the world is also responsible for hindering the growth of market.
North America to Dominate the Market
The Advance Wound Care Management market is segmented by product type, wound type, and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the advance wound care management market due to increasing incidences of chronic wounds, favorable reimbursement policies and rise in geriatric population. Europe is also expected to boost the growth of advance wound care management market due to increasing awareness of wound care management among geriatric population. Factors such as increasing accessibility to healthcare facilities in the region, rising medical tourism, and increasing prevalence of chronic diseases are also expected to contribute to the growth of market in this region.
Key Developments in the Market
- December 2017: Smith & Nephew announced European launch of MolecuLight i:X, which is a handheld imaging device that can be used to instantly measure wound surface area and visualize the presence of potentially harmful bacteria in it.
Reasons to Purchase this Report
- Market analysis for the Global Advance Wound Care Management Market, with region-specific assessments and competition analysis on a global and regional scale.
- Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
- The treatment type that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER'S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING INCIDENCES OF CHRONIC WOUNDS, ULCERS AND DIABETIC ULCERS
6.1.2 INCREASE IN VOLUME OF SURGICAL PROCEDURES WORLDWIDE
6.1.3 INCREASE IN AGEING POPULATION
6.2 MARKET RESTRAINTS
6.2.1 LACK OF REIMBURSEMENTS POLICIES
6.2.2 HIGH TREATMENT COSTS
6.4 KEY CHALLENGES
7. Market Segmentation
7.1 SEGMENTATION-BY PRODUCT
7.1.1 MOIST WOUND DRESSINGS
126.96.36.199 FILM DRESSINGS
188.8.131.52 FOAMS DRESSINGS
184.108.40.206 HYDROCOLLOID DRESSINGS
220.127.116.11 HYDROGEL DRESSINGS
18.104.22.168 COLLAGEN DRESSINGS
22.214.171.124 ALGINATE DRESSINGS
126.96.36.199 SILVER WOUND DRESSINGS
7.1.2 ACTIVE WOUND CARE
188.8.131.52 SKIN SUBSTITUTES
184.108.40.206 GROWTH FACTORS
7.1.3 THERAPY DEVICES
220.127.116.11 NEGATIVE PRESSURE WOUND THERAPY
18.104.22.168 PRESSURE RELIEF DEVICES
7.2 SEGMENTATION-BY WOUND TYPE
7.2.1 DIABETIC FOOT ULCER
7.2.2 PRESSURE ULCER
7.2.3 VENOUS LEG ULCER
7.2.4 ARTERIAL ULCER
7.2.5 SURGICAL WOUNDS
7.3 SEGMENTATION-BY GEOGRAPHY
7.3.1 NORTH AMERICA
22.214.171.124 UNITED STATES
126.96.36.199 UNITED KINGDOM
188.8.131.52 REST OF EUROPE
184.108.40.206 AUSTRALIA & NEW ZEALAND
220.127.116.11 SOUTH KOREA
18.104.22.168 REST OF ASIA-PACIFIC
7.3.4 MIDDLE EAST & AFRICA
22.214.171.124 SOUTH AFRICA
126.96.36.199 REST OF THE MIDDLE EAST & AFRICA
7.3.5 SOUTH AMERICA
188.8.131.52 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 CONVATEC GROUP PLC
9.3 SMITH & NEPHEW
9.4 MOLNLYCKE HEALTH CARE AB
9.5 3M COMPANY
9.7 DERMA SCIENCES INC.
9.8 BAXTER INTERNATIONAL
9.9 INTEGRA LIFESCIENCES
10. FUTURE OF THE MARKET